T. Kallinich

发表

“Periodic fever” without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis

B. Rudolph, D. Haffner, G. Burmester, 2005, Annals of the Rheumatic Diseases.

Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis

K. Minden, J. Klotsche, S. Nielsen, 2023, Journal of scleroderma and related disorders.

GKJR(Gesellschaft für Kinder- und Jugendrheumatologie)-Diagnose- und Therapieoptimierungsboard – neue Wege zu Diagnose und Therapie komplexer Erkrankungen

P. Oommen, C. Rietschel, M. Hufnagel, 2023, Zeitschrift fur Rheumatologie.

SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies

N. Unterwalder, C. Meisel, W. Stenzel, 2021, medRxiv.

Evidence-based treatment recommendations for familial Mediterranean fever . A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology

U. Kiltz, C. Weseloh, P. Oommen, 2019 .

Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease

A. Bakkaloğlu, S. Ozen, A. Duzova, 2008, Annals of the rheumatic diseases.

The clinical course of a child with CINCA/NOMID syndrome improved during and after treatment with thalidomide

J. Roth, H. Hoffman, T. Kallinich, 2005, Scandinavian journal of rheumatology.

Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus

N. Unterwalder, C. Meisel, U. Schneider, 2021, medRxiv.

Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever

S. Vastert, H. Ozdogan, K. Barron, 2015, Annals of the rheumatic diseases.